Healthcare - Biotechnology - NASDAQ - US
$ 55.13
-3.9 %
$ 9.27 B
Market Cap
-15.06
P/E
BALANCE SHEET
2.06 B
ASSETS
236 M
LIABILITIES
1.83 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Revolution Medicines, Inc.
| Current Assets | 1.88 B |
| Cash & Short-Term Investments | 1.85 B |
| Receivables | 1.25 M |
| Other Current Assets | 25.1 M |
| Non-Current Assets | 182 M |
| Long-Term Investments | 0 |
| PP&E | 100 M |
| Other Non-Current Assets | 82.4 M |
| Current Liabilities | 144 M |
| Accounts Payable | 61.8 M |
| Short-Term Debt | 14.7 M |
| Other Current Liabilities | 67.3 M |
| Non-Current Liabilities | 91.7 M |
| Long-Term Debt | 80.6 M |
| Other Non-Current Liabilities | 11.1 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 696.1 | 161.4 | 108.5 | 104.3 | 16.7 | 69.6 | 9.1 |
| Short Term Investments | 1 156.8 | 483.5 | 468.6 | 336.5 | 106.1 | 0 | 0 |
| Receivables | 1.3 | 4.7 | 5.9 | 6.4 | 8.7 | 7.3 | 0 |
| Inventory | 0 | 1 | (12.7) | 0 | 1 | 6.6 | 0 |
| Other Current Assets | 25.1 | 10.6 | 6.8 | 7.0 | 2.5 | 8.5 | 0.4 |
| Total Current Assets | 1 879.3 | 660.2 | 577.1 | 454.1 | 134.0 | 85.4 | 9.4 |
| PP&E | 100.0 | 73.7 | 71.2 | 36.3 | 7.1 | 6.9 | 5.3 |
| Intangible Assets | 57.7 | 58.8 | 59.9 | 60.9 | 62.0 | 63.1 | 0 |
| Goodwill | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 | 0 |
| Long Term Investments | 0 | 1.7 | 1.7 | 1.1 | 0.2 | 0.2 | 0 |
| Other Long Term Assets | 10.1 | (23.4) | (14.5) | (19.1) | (8.3) | (2.5) | 0.4 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 2 061.7 | 811.9 | 738.0 | 567.4 | 220.5 | 170.6 | 15.1 |
| LIABILITIES | |||||||
| Accounts Payable | 61.8 | 21.3 | 14.1 | 12.6 | 11.4 | 5.2 | 3.4 |
| Short Term Debt | 14.7 | 13.5 | 12.4 | 3.7 | 0.2 | 0.1 | 0 |
| Other Current Liabilities | 67.3 | 22.7 | 21.5 | 18.8 | 14.3 | 8.3 | 4.2 |
| Total Current Liabilities | 143.9 | 62.0 | 18.9 | 47.2 | 43.1 | 30.6 | 7.6 |
| Long Term Debt | 80.6 | 57.4 | 60.4 | 29.0 | 0 | 0 | 0 |
| Deferred Tax Income | 3.1 | 7.0 | 7.4 | 7.4 | 7.8 | 12.2 | 0 |
| Other Liabilities | 8.0 | 0.3 | 0.6 | 0.6 | 2.4 | 2.8 | 2.9 |
| Total Liabilities | 235.5 | 126.7 | 135.4 | 92.7 | 68.0 | 73.9 | 10.5 |
| EQUITY | |||||||
| Common Stock | 16 K | 9 K | 8 K | 7 K | 0 | 3 K | 1 K |
| Retained Earnings | (1 137.7) | (701.3) | (452.6) | (265.5) | (157.4) | (109.7) | (67.9) |
| Other Accumulative Comprehensive Income/Loss | 0.5 | (1.8) | (0.4) | 0.1 | 74 K | (3.6) | (2.2) |
| Total Equity | 1 826.2 | 685.2 | 602.6 | 474.7 | 152.5 | 96.7 | 4.5 |
| Total Liabilities and Equity | 2 061.7 | 811.9 | 738.0 | 567.4 | 220.5 | 170.6 | 15.1 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 113.1 | 80.6 | 72.8 | 66.6 | 59.0 | 36.5 | 36.5 |